Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments ; volume:1 ; number:1 ; day:9 ; month:8 ; year:2011 ; pages:1-9 ; date:12.2011
Annals of intensive care ; 1, Heft 1 (9.8.2011), 1-9, 12.2011
- Creator
-
Honore, Patrick M.
Jacobs, Rita
Joannes-Boyau, Olivier
De Regt, Jouke
Boer, Willem
De Waele, Elisabeth
Collin, Vincent
Spapen, Herbert D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2110-5820-1-32
- URN
-
urn:nbn:de:101:1-2019091819273552149598
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Jacobs, Rita
- Joannes-Boyau, Olivier
- De Regt, Jouke
- Boer, Willem
- De Waele, Elisabeth
- Collin, Vincent
- Spapen, Herbert D.
- SpringerLink (Online service)
Other Objects (12)
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Adsorption and caspofungin dosing during continuous renal replacement therapy
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?